RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q3 2014 (← Previous) (Next →)

Filing Date: Nov 14, 2014

Total Value: $846M (100.0% shares, 0.0% debt)

Holdings (46)

ACAD ACADIA PHARMACEUTICALS INC 15.4%
Value $130M Shares 5,250,000 Est. Cost $23.39 Unrealized 0.0%
DYAX CORP 9.3%
Value $79.03M Shares 7,809,139 Est. Cost $8.24 Unrealized
BCRX BIOCRYST PHARMACEUTICALS 8.2%
Value $69.14M Shares 7,069,159 Est. Cost $9.01 Unrealized +36.1%
ACHILLION PHARMACEUTICALS INC 7.9%
Value $66.87M Shares 6,700,000 Est. Cost $4.78 Unrealized
SGMO SANGAMO BIOSCIENCES INC 7.6%
Value $64.71M Shares 6,000,000 Est. Cost $9.24 Unrealized +41.3%
AVANIR PHARMACEUTICALS INC 7.6%
Value $64.21M Shares 5,386,700 Est. Cost $11.92 Unrealized
SUNESIS PHARMACEUTICALS INC 4.1%
Value $34.77M Shares 4,869,261 Est. Cost $5.18 Unrealized
DICERNA PHARMACEUTICALS INC 3.7%
Value $30.92M Shares 2,428,571 Est. Cost $28.25 Unrealized
ACHILLION PHARMACEUTICALS IN 3.5%
Value $29.94M Shares 3,000,000 Est. Cost $4.78 Unrealized
BLUEBIRD BIO INC 3.1%
Value $26.15M Shares 728,812 Est. Cost $30.29 Unrealized
OPHTHOTECH CORP 2.7%
Value $22.93M Shares 588,941 Est. Cost $33.27 Unrealized
ZS PHARMA INC 2.6%
Value $22.14M Shares 564,483 Est. Cost $39.23 Unrealized
TGTX TG THERAPEUTICS INC 2.6%
Value $22.04M Shares 2,065,571 Est. Cost $9.27 Unrealized 0.0%
NOVAVAX INC 2.5%
Value $21.13M Shares 5,067,083 Est. Cost $2.24 Unrealized
DYNAVAX TECHNOLOGIES CORP 2.1%
Value $17.42M Shares 12,179,002 Est. Cost $1.67 Unrealized
VERSARTIS INC 2.0%
Value $17.07M Shares 898,993 Est. Cost $41.65 Unrealized
THERAPEUTICSMD INC 1.9%
Value $16.03M Shares 3,454,332 Est. Cost $3.00 Unrealized
ZAFGEN INC 1.7%
Value $14.4M Shares 732,960 Est. Cost $19.65 Unrealized
AKBA AKEBIA THERAPEUTICS INC 1.6%
Value $13.22M Shares 597,363 Est. Cost $24.08 Unrealized -4.6%
SGMO SANGAMO BIOSCIENCES INC 1.6%
Value $13.16M Shares 1,220,209 Est. Cost $9.24 Unrealized +41.3%
XNCR XENCOR INC 1.4%
Value $11.63M Shares 1,248,923 Est. Cost $8.86 Unrealized +14.1%
ENTA ENANTA PHARMACEUTICALS INC 1.2%
Value $9.893M Shares 250,000 Est. Cost $36.32 Unrealized +9.7%
TENAX THERAPEUTICS INC 1.1%
Value $9.182M Shares 2,336,375 Est. Cost $3.93 Unrealized
SCYNEXIS INC 0.7%
Value $6.208M Shares 840,000 Est. Cost $8.02 Unrealized
VICAL INC 0.7%
Value $6.132M Shares 5,475,419 Est. Cost $1.12 Unrealized
AURIS MED HLDG AG 0.6%
Value $5.424M Shares 940,000 Est. Cost $5.77 Unrealized
T2 BIOSYSTEMS INC 0.3%
Value $2.496M Shares 138,002 Est. Cost $18.09 Unrealized
WAFERGEN BIO-SYSTEMS INC 0.3%
Value $2.436M Shares 560,000 Est. Cost $4.35 Unrealized
OCERA THERAPEUTICS INC 0.2%
Value $2.046M Shares 417,476 Est. Cost $11.51 Unrealized
ALIMERA SCIENCES INC 0.2%
Value $1.321M Shares 243,726 Est. Cost $7.89 Unrealized
CDXS CODEXIS INC 0.1%
Value $1.175M Shares 504,279 Est. Cost $2.15 Unrealized 0.0%
PTCT PTC THERAPEUTICS INC 0.1%
Value $1.135M Shares 25,800 Est. Cost $31.28 Unrealized 0.0%
AGIO AGIOS PHARMACEUTICALS INC 0.1%
Value $1.08M Shares 17,600 Est. Cost $43.10 Unrealized 0.0%
VRTX VERTEX PHARMACEUTICALS INC 0.1%
Value $1.044M Shares 9,300 Est. Cost $95.21 Unrealized 0.0%
MERRIMACK PHARMACEUTICALS INC 0.1%
Value $1.022M Shares 116,400 Est. Cost $8.78 Unrealized
RGEN REPLIGEN CORP 0.1%
Value $896K Shares 45,000 Est. Cost $21.05 Unrealized 0.0%
REGN REGENERON PHARMACEUTICALS 0.1%
Value $883K Shares 2,450 Est. Cost $333.32 Unrealized 0.0%
BIIB BIOGEN IDEC INC 0.1%
Value $860K Shares 2,600 Est. Cost $329.72 Unrealized 0.0%
AMGN AMGEN INC 0.1%
Value $829K Shares 5,900 Est. Cost $94.52 Unrealized 0.0%
CELGENE CORP 0.1%
Value $825K Shares 8,700 Est. Cost $94.83 Unrealized
ALKS ALKERMES PLC 0.1%
Value $823K Shares 19,200 Est. Cost $44.82 Unrealized 0.0%
KERYX BIOPHARMACEUTICALS INC 0.1%
Value $814K Shares 59,200 Est. Cost $13.75 Unrealized
KYTHERA BIOPHARMACEUTICALS 0.1%
Value $745K Shares 22,750 Est. Cost $32.75 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 0.1%
Value $743K Shares 30,000 Est. Cost $23.39 Unrealized 0.0%
PBYI PUMA BIOTECHNOLOGY INC 0.1%
Value $740K Shares 3,100 Est. Cost $205.34 Unrealized 0.0%
NEWLINK GENETICS CORP 0.1%
Value $643K Shares 30,000 Est. Cost $21.43 Unrealized